Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Massive registry launches to track heart ablation outcomes

NCT ID NCT05111015

Disease control Sponsor: AtriCure, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This study is tracking 10,000 people with atrial fibrillation who are having a heart ablation procedure. The goal is to see how well the procedure works and how safe it is in everyday medical practice. Researchers will measure how much AF burden patients have 6 months after the procedure and record any side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 10,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2024

Expected to finish

Jan 2040

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The TRAC-AF registry eligibility is open to sites and physicians performing open concomitant or hybrid ablation therapy procedures as treatments for patients diagnosed with paroxysmal, persistent or long-standing persistent atrial fibrillation using at least one of AtriCure's ablation devices. Subjects must have been scheduled to undergo or have undergone the cardiac ablation treatment and must meet all eligibility criteria in order for their treatment and results to be considered for this registry.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patient has been scheduled by physician(s) to undergo or has undergone cardiac ablation procedure(s) 2. Patient is willing to provide informed consent 3. Patient whose age is 18 years or above, or of legal age to give informed consent specific to state and national law Exclusion Criteria: 1\. Other medical, social, or psychological conditions that in the opinion of the Investigator precludes the subject from appropriate consent or adherence to the protocol.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Atrial fibrillation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Atrial fibrillation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    29 sites in 3 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Adventist Heart Institute (St. Helena Hospital)

    RECRUITING

    St. Helena, California, 94574, United States

  • Atrium Health Wake Forest Baptist

    RECRUITING

    Winston-Salem, North Carolina, 27157, United States

  • CHI St. Vincent Heart Institute

    RECRUITING

    Little Rock, Arkansas, 72205, United States

  • Centennial Medical Center

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • Corewell Health

    RECRUITING

    Grand Rapids, Michigan, 49503, United States

  • Delray Medical Center

    RECRUITING

    Delray Beach, Florida, 33484, United States

  • Franciscan Health

    RECRUITING

    Indianapolis, Indiana, 46237, United States

  • Huntsville Hospital

    RECRUITING

    Huntsville, Alabama, 35801, United States

  • Jackson Madison County General Hospital

    RECRUITING

    Jackson, Tennessee, 38301, United States

  • Kansas City Heart Rhythm Institute

    RECRUITING

    Overland Park, Kansas, 66211, United States

  • Loma Linda University Medical Center

    RECRUITING

    Loma Linda, California, 92354, United States

  • Maimonides Health Heart & Vascular Institute

    RECRUITING

    Brooklyn, New York, 11219, United States

  • MedStar Washington Hospital

    RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • Medical College of Wisconsin

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

  • Medical University of Vienna

    RECRUITING

    Vienna, Austria

  • Michael E. DeBakey VAMC - Houston

    RECRUITING

    Houston, Texas, 77030, United States

  • Norton Heart & Vascular Institute

    RECRUITING

    Louisville, Kentucky, 40222, United States

  • Nova Scotia Health Authority

    RECRUITING

    Halifax, Nova Scotia, B3H3A7, Canada

  • Orlando Health Heart & Vascular Institute

    RECRUITING

    Orlando, Florida, 32806, United States

  • St. Bernards Medical Center

    RECRUITING

    Jonesboro, Arkansas, 72401, United States

  • St. Joseph's Hospital (BayCare)

    RECRUITING

    Tampa, Florida, 33607, United States

  • UH Cleveland Harrington Heart & Vascular Institute

    RECRUITING

    Cleveland, Ohio, 44106, United States

  • University of Florida

    RECRUITING

    Gainesville, Florida, 32608, United States

  • University of Michigan

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

  • University of Nebraska Medical Center

    RECRUITING

    Omaha, Nebraska, 68198, United States

  • Valley View Hospital

    RECRUITING

    Glenwood Springs, Colorado, 81601, United States

  • Vassar Brothers Medical Center

    RECRUITING

    Poughkeepsie, New York, 12601, United States

  • Washington University School of Medicine

    RECRUITING

    St Louis, Missouri, 63110, United States

  • Waterloo Regional Health Network

    RECRUITING

    Kitchener, Ontario, N2M1B2, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.